Mercury Pharmaceuticals

18

Oct 2026

What you did last week may be the strongest clue to how much you'll exercise this week

Researchers analyzing exercise records from 5.17 million Strava users across 65 countries found that recent exercise history was the strongest predictor of whether individuals would meet a weekly physical activity threshold during the COVID-19 pandemic. Physical activity patterns varied considerably across regions, with greater disruption in many middle-income countries and better adherence associated with greater access to outdoor exercise facilities.

READ MORE

18

Oct 2026

Yoghurt, coffee and chocolate have something in common, and researchers mapped it across Europe

Researchers surveyed 12,646 adults across 53 European countries and found that fermented dairy products were widely consumed, while other fermented foods showed considerable regional differences in popularity and intake. The findings revealed that high consumer prevalence did not necessarily translate into substantial consumption, highlighting the importance of measuring both how many people eat fermented foods and the quantities they consume.

READ MORE

18

Oct 2026

You don't need 10,000 steps a day to benefit your heart, cardiologists say

A new American College of Cardiology scientific statement recommends integrating individualized exercise prescriptions into routine cardiovascular care, drawing on evidence supporting aerobic activity, resistance training, and cardiac rehabilitation. The authors emphasize that previously inactive individuals have the most to gain from increasing physical activity, while exercise recommendations should consider individual health conditions, functional capacity, and safety.

READ MORE

18

Oct 2026

Your age may not tell the whole story about your health, but your blood could

Researchers analyzed plasma metabolites from 18,476 individuals aged 1 to 96 years and developed two metabolomic aging measures to assess biological aging, chronic disease, and mortality risk. Accelerated metabolomic aging was associated with greater risks of chronic disease and death, while a separate mortality-linked measure provided additional information about health status and disease burden beyond conventional clinical assessments.

READ MORE

16

Oct 2026

Neurotechnology offers hope for better anxiety and depression treatments

Technology can contribute to better treatment for people struggling with anxiety and depression, according to researcher Sandra Klonteig.

READ MORE

16

Oct 2026

New Food-Sharing Compass platform to be launched at the final event of CULTIVATE project

The new platform, known as the Food-Sharing Compass, will be unveiled at the final event of the EU-funded CULTIVATE project which created it for the wider food-sharing community.

READ MORE

16

Oct 2026

New surgical technique enlarges aortic roots for larger valve implants

When replacing the aortic valve, a small aortic root can limit the size of the prosthetic valve that can be implanted.

READ MORE

16

Oct 2026

Does adding yeast to whey protein help muscle recovery after exercise?

The yeast-whey protein blend shows potential in aiding muscle recovery after exercise-induced damage, yet its effectiveness compared to whey alone is uncertain.

READ MORE

16

Oct 2026

Invisible no more: New treatment avenue unlocked for deadliest lung cancer

Researchers have uncovered a previously overlooked immune cell that can recognize and kill small cell lung cancer, the most aggressive form of the disease globally.

READ MORE

16

Oct 2026

invIOs publishes positive clinical data on CBL-B-silenced autologous cell therapy APN401 in peer-reviewed journal

invIOs GmbH (“invIOs”), a privately held biotechnology company developing innovative cancer immunotherapies, today announced the publication of new clinical data with its autologous PBMC (peripheral blood mononuclear cell) therapy APN401 in the peer-reviewed journal, Molecular Therapy Oncology.

READ MORE